Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Patricia Lesho"'
Autor:
Yamini K. Kathari, Haroon Ahmad, Michael E. Kallen, Rima Koka, Destiny Omili, Thierry Iraguha, Jean Clement, Lily Pham, Mazhar Khalid, Xiaoxuan Fan, Etse Gebru, Patricia Lesho, Esther Park, Nishanthini Dishanthan, Jillian M. Baker, Kenneth A. Dietze, Kim G. Hankey, Ashraf Badros, Jean A. Yared, Saurabh Dahiya, Nancy M. Hardy, Hakan Kocoglu, Tim Luetkens, Aaron P. Rapoport, Djordje Atanackovic
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/5c8f409c192e46238e508a86a23d69fd
Autor:
Kapil K Saharia, Jennifer S Husson, Silke V Niederhaus, Thierry Iraguha, Stephanie V Avila, Youngchae J Yoo, Nancy M Hardy, Xiaoxuan Fan, Destiny Omili, Alice Crane, Amber Carrier, Wen Y Xie, Erica Vander Mause, Kim Hankey, Sherri Bauman, Patricia Lesho, Heather D Mannuel, Ashish Ahuja, Minu Mathew, James Avruch, John Baddley, Olga Goloubeva, Kirti Shetty, Saurabh Dahiya, Aaron P Rapoport, Tim Luetkens, Djordje Atanackovic
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 5, Pp n/a-n/a (2022)
Abstract Objectives Solid organ transplant recipients (SOTR) receiving post‐transplant immunosuppression show increased COVID‐19‐related mortality. It is unclear whether an additional dose of COVID‐19 vaccines can overcome the reduced immune
Externí odkaz:
https://doaj.org/article/93a523e0f0174ab7847532c36cefb624
Autor:
Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M. Hardy, Xiaoxuan Fan, Stephanie V. Avila, Kapil K. Saharia, Jennifer S. Husson, Silke V. Niederhaus, Philip Margiotta, Seung T. Lee, Jennie Y. Law, Heather D. Mannuel, Erica Vander Mause, Sherri Bauman, Patricia Lesho, Kim Hankey, John Baddley, Mehmet Kocoglu, Jean A. Yared, Aaron P. Rapoport, Saurabh Dahiya
Publikováno v:
Blood. 140:152-156
Patients receiving CD19 CAR T-cell therapy for relapsed/refractory lymphoma experience prolonged and profound B-cell aplasia and hypogammaglobulinemia, placing them at a higher risk for severe COVID-19. Independently, Oh et al and Atanackovic et al d
Autor:
Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie Avila, Thierry Iraguha, Philip Margiotta, Kim G. Hankey, Patricia Lesho, Jennie Y. Law, Seung T. Lee, John Baddley, Mehmet Kocoglu, Jean A. Yared, Nancy M. Hardy, Aaron P. Rapoport, Djordje Atanackovic
Publikováno v:
Blood Advances
Autor:
Kapil K. Saharia, Jennifer S. Husson, Silke V. Niederhaus, Thierry Iraguha, Stephanie V. Avila, Youngchae J. Yoo, Nancy M. Hardy, Xiaoxuan Fan, Destiny Omili, Alice Crane, Amber Carrier, Wen Y. Xie, Erica Vander Mause, Kim Hankey, Sheri Bauman, Patricia Lesho, Heather D. Mannuel, Ashish Ahuja, Minu Mathew, James Avruch, John Baddley, Olga Goloubeva, Kirti Shetty, Saurabh Dahiya, Aaron P. Rapoport, Tim Luetkens, Djordje Atanackovic
BackgroundSolid organ transplant recipients (SOTR), who typically receive post-transplant immunosuppression, show increased COVID-19-related mortality. It is unclear whether an additional dose of COVID-19 vaccines in SOTR can overcome the reduced imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa251084972f92af72b7f43c264d059d
https://doi.org/10.1101/2021.12.29.21268529
https://doi.org/10.1101/2021.12.29.21268529
Autor:
Rupa Narayan, Robert P. Hasserjian, Margaret C. Wey, Tanya T. Behnan, Meghan Bergeron, Jessica Rae, Mason L. Mann, Ashkan Emadi, Christina Bertoli, Eyal C. Attar, Traci M. Blonquist, Christopher Lescinskas, Jenna A. Moran, Yi-Bin Chen, Steven L. McAfee, Vu H. Duong, Patricia Lesho, Timothy A. Graubert, Jennifer Lombardi Story, Andrew M. Brunner, Meghan Burke, Megan K. Vartanian, Gabriela S. Hobbs, Tina T. Som, Donna Neuberg, Hanno Hock, Molly Macrae, Julia Foster, Kristin McGregor, Philip C. Amrein, Amir T. Fathi, Karen K. Ballen, Frederic I. Preffer, Aura Y. Ramos, Christine Connolly
Publikováno v:
Cancer. 126:1264-1273
Background Outcomes for patients with relapsed/refractory acute myeloid leukemia (R/R AML) remain poor. Novel therapies specifically targeting AML are of high interest. Brentuximab vedotin (BV) is an antibody-drug conjugate that is specific for human
Autor:
Nancy M. Hardy, Kim G. Hankey, Seung Tae Lee, Aaron P. Rapoport, Mehmet Hakan Kocoglu, Nancy Smith, Tim Luetkens, Patricia Lesho, Sherri Bauman, Djordje Atanackovic, Jean A. Yared, Kathleen Ruehle, John W Baddley, Philip Margiotta, Stephanie Avila, Jennie Y. Law, Saurabh Dahiya
Publikováno v:
Blood
Introduction: Patients with hematologic malignancies are at an increased risk of morbidity and mortality from COVID-19 disease (Vijenthira, Blood 2020). This is likely a result of combination of immunodeficiency conferred by the disease and the thera
Autor:
Karen K. Ballen, Steven L. McAfee, Meghan Bergeron, Robert P. Hasserjian, Meghan Burke, Mason L. Mann, Tanya T. Behnan, Aura Y. Ramos, Jennifer Lombardi Story, Vu H. Duong, Traci M. Blonquist, Philip C. Amrein, Hanno Hock, Kaitlyn M. Fishman, Gabriela S. Hobbs, Frederic I. Preffer, Andrew M. Brunner, Megan K. Vartanian, Molly Macrae, Christine Connolly, Ashkan Emadi, Christina Bertoli, Donna Neuberg, Patricia Lesho, Amir T. Fathi, Jenna A. Moran, Christopher Lescinskas, Kristin McGregor, Tina T. Som, Julia Foster
Publikováno v:
Blood. 132:1431-1431
Background: Brentuximab vedotin (BV) is an antibody-drug conjugate (ADC) consisting of an antibody specific for human CD30, an anti-microtubule agent monomethyl auristatin E (MMAE), and a protease-cleavable linker attaching MMAE to the antibody. BV i
Autor:
Sunita Philip, Ning Ma, Patricia Lesho, Ashlee Johnson, Olga Goloubeva, Mehmet H. Kocoglu, Elizabeth Hyjek, Alexander M. Lesokhin, Aaron P. Rapoport, Cameron Dell, Emily Lederer, Zeba N. Singh, Ashraf Badros
Publikováno v:
Blood. 128:490-490
BACKGROUND: Immunotherapy in MM is emerging as an effective modality in therapy of MM with the approval of several monoclonal antibodies and encouraging results for vaccines and T cell therapy. Programmed death 1 (PD-1) receptor and its ligand (PD-L1
Autor:
Sunita Philip, Mehmet H. Kocoglu, Zeba N. Singh, Emily Lederer, Cameron Dell, Nancy M. Hardy, Jean A. Yared, Olga Goloubeva, Aaron P. Rapoport, Ning Ma, Patricia Lesho, Ashraf Badros
Publikováno v:
Blood. 126:506-506
BACKGROUND: Several recent studies have linked the interactions of programmed death 1 (PD-1) receptor and its ligand (PD-L1) to immunologic control of MM. Expression of PD-L1 on myeloma cells and the abundance of PD-1 on various bone marrow microenvi